More than a financial investment, CCNA’s Partner Organizations share the vision of leading in the prevention, treatment, and management of the neurodegenerative diseases of aging. The CCNA is a Government of Canada initiative, also supported by several national, provincial and industry organizations:
Canadian Institutes of Health Research
The Canadian Institutes of Health Research (CIHR) is the Government of Canada’s health research investment agency. CIHR’s mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened health care system for Canadians. Composed of 13 Institutes, CIHR provides leadership and support to more than 13,000 health researchers and trainees across Canada.
Partner Organizations
Alberta Prion Research Institute (APRI)
The Alberta Prion Research Institute is committed to the prevention, mitigation and treatment of prion and protein misfolding diseases in animals and humans. The Alberta Prion Research Institute invests in fundamental and applied research that takes an interdisciplinary approach to solving the prion mystery. It supports projects that focus on innovation and invention.
The Alberta Prion Research Institute’s immediate goal is to fund research that helps unfold the mysteries of prion and protein misfolding behaviour; prevent and manage prion and prion-like diseases; and address the economic, environmental, social and economic consequences of these diseases. While working to achieve that goal, the Alberta Prion Research Institute is building research capacity and expertise in Alberta.
Alzheimer Society of Canada (ASC)
Established in 1978, the Alzheimer Society is the leading nationwide health charity for people living with Alzheimer’s disease and other dementias, their caregivers and families. Active in communities across Canada, the Society offers help for today through a wide range of programs and services, and hope for tomorrow by funding innovative research into the cause and cure. The Society also works to raise public awareness, reduce stigma and advocate for policy change. Our vision is a world without Alzheimer’s disease.
Alzheimer Research UK (ARUK)
Alzheimer’s Research UK is the leading dedicated charity funder of dementia research in the world. We are committed to funding to best biomedical research to fulfil our vision of a world where people are free from the fear, harm and heartbreak of dementia.
Our focus is to accelerate the ‘bench-to-bedside’ journey and we have launched a number of initiatives to make our ambitious Research Strategy a reality. Our £30 million Drug Discovery Alliance is one of the largest coordinated academic efforts in the world to boost the early-stage dementia drug discovery pipeline. We also partner extensively with industry including through the Dementia Consortium – a unique charity-private partnership to fund robust target validation. We are pleased to contribute to a number of UK and global partnerships, including the CCNA.
As a charity we are also working hard to raise dementia awareness across society and to shape and influence policy on dementia research by working with key decision makers in government and beyond.
Canadian Nurses Foundation (CNF)
Vision: Excellence in Nursing Care
Mission: To advance nursing knowledge and improve health care by providing scholarships, awards, and research grants to nurses and nursing students in Canada.
The Consortium for the early identification of Alzheimer’s disease (CIMA-Q) gathers more than 90 Quebec based researchers and clinicians who share the common ambition of advancing knowledge on Alzheimer’s disease. More specifically, the aim is to develop tools to detect the very first signs of the disease. Early detection of Alzheimer’s disease greatly increases the chances of success of any type of interventions, thus improving the quality of life of seniors afflicted with this terrible disease.
The Consortium for the early identification of Alzheimer’s disease – Quebec (CIMA-Q)
The Consortium for the early identification of Alzheimer’s disease (CIMA-Q) gathers more than 90 Quebec based researchers and clinicians who share the common ambition of advancing knowledge on Alzheimer’s disease. More specifically, the aim is to develop tools to detect the very first signs of the disease. Early detection of Alzheimer’s disease greatly increases the chances of success of any type of interventions, thus improving the quality of life of seniors afflicted with this terrible disease.
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by Colonel Eli Lilly, who was committed to creating high quality medicines that meet people’s needs, and today we remain true to that mission in all our work. Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and contribute to our communities through philanthropy and volunteerism.
Eli Lilly Canada was established in 1938, the result of a research collaboration with scientists at the University of Toronto which eventually produced the world’s first commercially-available insulin. Lilly Canada now employs nearly 400 people across the country, working in the areas of oncology, diabetes, autoimmunity, neurodegeneration, and pain. To learn more about Lilly Canada, please visit us at www.lilly.ca.
Fonds de recherche du Québec – Santé (FRQS)
The mission of the Fonds de recherche du Québec – Santé (FRQS), is to develop and support health research in order to foster the well-being of the population, to reinforce the health and social services system and to contribute to the knowledge-based society in Quebec, Canada and internationally.
Michael Smith Foundation for Health Research (MSFHR)
The Michael Smith Foundation for Health Research empowers British Columbia’s (BC) best and brightest health researchers to pursue world-class innovation and stretch the bounds of what health research can achieve. The Foundation helps BC’s health research community discover solutions to our greatest health challenges; connect knowledge and action on provincial priorities; and engage partners to improve the research enterprise.
New Brunswick Health Research Foundation (NBHRF)
The New Brunswick Health Research Foundation (NBHRF) was created in July 2008 with a mandate to co-ordinate, support and promote health research in New Brunswick. Our vision is a healthy and prosperous New Brunswick through excellence in health research and innovation. Our mission is to provide leadership and support to build health research capacity, improve the health of New Brunswickers and advance the knowledge economy.
Nova Scotia Health Research Foundation (NSHRF)
The Nova Scotia Health Research Foundation (NSHRF) exists to improve the health of Nova Scotians through health research. This is accomplished by working with stakeholders, including the provincial government, health authorities, and health researchers on a number of initiatives and funding opportunities.
Through its support of researchers, students and knowledge translation activities, the Foundation is maximizing the impact of health research on informed decision making in Nova Scotia and across the country.
Ontario Brain Institute (OBI)
Our task at the Ontario Brain Institute is to draw researchers together into seamless, convergent partnerships with clinicians, industry, patients and their advocates. The goal: to facilitate the kind of continual interaction and discovery among these players that delivers innovative services and products for brain-related health care.
The Institute is a government-funded, not-for-profit initiative whose scope spans the entire continuum of brain science and treatment. As a virtual research centre, we have no labs and conduct no research of our own. Instead, our projects and programs are focused on bringing actors and elements together and enabling their interaction. In doing so, we’re turning Ontario’s world caliber brain science into:
- Successful Ontario companies and good jobs;
- Data and knowledge that can be shared with the world, and that will attract investment in Ontario;
- Commercialization of new treatments; and
- Improved patient care.
Our work is in support of a single vision: Ontario as a world leader in brain discovery, commercialization and care.
Pfizer
Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., one of the world’s leading biopharmaceutical companies. Our diversified health care portfolio includes some of the world’s best known and most prescribed medicines and vaccines. Every day, Pfizer Canada employees work to bring therapies to patients that significantly improve patients’ lives. Pfizer is a major contributor to health research in Canada. We apply science and our global resources to improve the health and well-being of Canadians at every stage of life. Our commitment is reflected in everything Pfizer does, from our disease awareness initiatives to our community partnerships.
Robin and Barry Picov Family Foundation
The Robin and Barry Picov Family Foundation is excited to participate as a partner of the CCNA through the auspices of the Women’s Brain Health Initiative. In addition to better understanding the impact of brain-aging diseases on both men and women, our hope is that the research proposed will result in better treatment and, ideally, innovative prevention strategies, for all neurodegenerative diseases in aging.
Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme.
Saskatchewan Health Research Foundation (SHRF)
The Saskatchewan Health Research Foundation (SHRF) is the provincial agency responsible for funding, facilitating and promoting innovative, collaborative health research in Saskatchewan. SHRF works as a catalyst, driver, and leader to: build and broaden the province’s research capacity; expedite the production and sharing of knowledge; increase stakeholder engagement; generate new and diverse funding partnerships; and measure the impact of health research on our Saskatchewan communities.
Women’s Brain Health Initiative (WBHI)
It was frightening to learn that women suffer from depression, stroke and dementia twice as much as men as they age, and an astounding 70 percent of new Alzheimer’s patients are women. Yet research still focuses on men. We want to correct this research bias. Women’s Brain Health Initiative is a charitable non-profit organization with a mandate to provide education and fund research to combat brain-aging diseases that affect women.
Interested in Partnering with the CCNA?
Partnership Opportunities
The Alzheimer Society of Canada’s Rising Tide report makes it clear that inaction is not an option. Maintaining the status quo would mean that, by 2038:
- 1, 125, 200 Canadians will have dementia (i.e. 1 new case every 2 minutes)
- Canada will face $872 billion combined economic burden
- Demand for long-term care will increase by 10X
Help reverse the tide by partnering with the Canadian Consortium on Neurodegeneration in Aging. Connections and partnerships are welcomed with other networks, agencies, and organizations.
Interested? Complete and submit this Expression of Interest Form: